NASDAQ:RLMD | Free Cash Flow | RELMADA THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-08-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$15.07M
2025-12-31-$14.6M
2025-03-31-$18.07M
2024-12-31-$8.8M
2024-03-31-$13.04M
2023-12-31-$10.25M
2023-03-31-$16.51M
2022-12-31-$35.88M
2022-03-31-$19.43M
2021-12-31-$37.66M
2021-03-31-$16.09M
2020-12-31-$6.93M
2020-03-31-$3.42M
2019-12-31-$3.88M
2019-09-30-$2.53M
2019-06-30-$3.67M
2019-03-31-$2.01M
2018-09-30-$1.67M
2018-06-30-$2.27M
2017-09-30-$979,048.00
2017-06-30-$1.02M
2016-09-30-$2.14M
2016-06-30-$2.83M
2015-09-30-$3.22M
2015-06-30-$4.49M
2014-09-30-$2.32M
2013-11-30-$9,124.00
2013-09-30-$408,700.00
2013-08-31-$5,374.00$0.00-$5,374.00
2012-11-30$1,497.00
2012-08-31-$3,344.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$45.79M
2024-12-31-$51.76M
2023-12-31-$51.66M
2022-12-31-$103.8M
2021-12-31-$91.87M
2020-12-31-$27.81M
2019-12-31-$12.09M
2019-06-30-$10.5M
2018-06-30-$6M
2017-06-30-$6.47M
2016-06-30-$13.14M
2015-06-30-$16.23M
2013-12-31-$2.24M
2013-08-31-$11,859.00-$1,800.00-$13,659.00
2012-08-31-$7,565.00